Optimizing Dyslipidemic Cardiovascular Residual Risk Reduction with Icosapent Ethyl in Post-MI Patients: Key Takeaways •
iHeart

Focus on Heart Health

Optimizing Dyslipidemic Cardiovascular Residual Risk Reduction with Icosapent Ethyl in Post-MI Patients: Key Takeaways

00:0000:00
Focus on Heart Health

Optimizing Dyslipidemic Cardiovascular Residual Risk Reduction with Icosapent Ethyl in Post-MI Patients: Key Takeaways

May 30, 2022 0 sec

From Paper to Patient: Applying Guideline Updates to Practice

Apr 29, 2022 0 sec

The 4 Pillars of Treatment in HFrEF: Does Risk of Hyperkalemia Threaten to Topple Them Over?

Apr 29, 2022 0 sec

Living with Heart Disease: How a Patient Gave Her Diagnosis Meaning

Apr 29, 2018 0 sec

Time for a Heart-to-Heart: Reflections of Life on the Transplant List

Mar 5, 2018 0 sec

Listen to more episodes